SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 83.68+0.1%Nov 28 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (2889)6/4/2010 3:15:02 PM
From: Jibacoa  Read Replies (1) of 3722
 
GNMK was up 5.85% at 2.:25pm but has had some downticks and is now down 1.41%

The stock apparently wants to close some of the UG on June 1st, its 2nd day of trading.<g>

bigcharts.marketwatch.com

GNMK has 4Qs of better revenues and was trimming some it losses, but the loss on the 1stQ (March) was a little higher.<g>

It slashed its IPO price and the money it expected to raise by more than 21%.It cut the amount it expected to raise by about $10M to $36.2M.

GNMK focuses on molecular tests for a range of conditions, including an FDA approved test for cystic fibrosis. It is developing other tests, including respiratory viruses.Its target markets are hospitals and reference labs.

It has said that it plans to spend $15M on test development, $10M for sales & marketing, and the rest for 'general corporate purposes'.<g>

The NAZ is now down 74 points getting close to the 2200 level and the DOW down close to 300 points, it seems that it will close below the "Maginot Line".
It seems still better to keep the powder dry. <g>

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext